Nj Institute For The Advancement Of Bloodless Medicine And Surgery - NJ Bergen, Englewood 07631

Nj Institute For The Advancement Of Bloodless Medicine And Surgery entered the industry of Hospitals in 1995 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 622110, which describes it as a Hospitals. For further clarification, the SIC classifies this business under the code 8062 and described it as a Hospitals. The business provides service to the B2C market.

To acquire more information, please contact Sherri Ozawa by calling (201) 894-3653 during business hours. You can also write to the business’ Single Location at 350 Engle St, Englewood, New Jersey NJ 07631. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Nj Institute For The Advancement Of Bloodless Medicine And Surgery
Representative: Sherri Ozawa
Place of Business: 350 Engle St, Englewood, NJ 07631
Contact Number: (201) 894-3653
Type of Service: Hospitals
SIC Number: 8062
NAICS Number: 622110
Locality: Single Location
Market Type: B2C (Business to Consumer)
Began: 1995
Income/Year: Unknown
Laborers: 1 to 4
Share This Company:

Nj Institute For The Advancement Of Bloodless Medicine And Surgery is a company operating from Bergen, New Jersey providing professional Hospitals and relevant B2C variables. It was founded in 1995 and registered with the SIC code 8062 as Hospitals, and with the NAICS code 622110 as Hospitals.

With a current employee count of 1 to 4, Nj Institute For The Advancement Of Bloodless Medicine And Surgery has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Sherri Ozawa at (201) 894-3653 for related queries, or to locate its Single Location using the coordinates 40.904845,-73.967194.

The Single Location can also be found at the street address 350 Engle St in Englewood, New Jersey 07631 and can be engaged online through the company website at , the company Twitter , and Facebook page .